Regulation of Plasma High-Density Lipoprotein Levels by the ABCA1 Transporter and the Emerging Role of High-Density Lipoprotein in the Treatment of Cardiovascular Disease-Reference-Cited by-同舟云学术

Regulation of Plasma High-Density Lipoprotein Levels by the ABCA1 Transporter and the Emerging Role of High-Density Lipoprotein in the Treatment of Cardiovascular Disease

Published:2004-10 Issue:10 Volume:24 Page:1755-1760
ISSN:1079-5642
Container-title:Arteriosclerosis, Thrombosis, and Vascular Biology
language:en
Short-container-title:ATVB

Author:

Brewer H. Bryan¹,Remaley Alan T.¹,Neufeld Edward B.¹,Basso Federica¹,Joyce Charles¹

Affiliation:

1. From the Molecular Disease Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference73 articles.

1. Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis

2. High-Density Lipoprotein — The Clinical Implications of Recent Studies

3. Lipids and risk of coronary heart disease The Framingham Study

4. The plasma lecithin:cholesterol acyltransferase reaction

5. Assmann G von Eckardstein A Brewer HBJ. Familial high density lipoprotein deficiency: Tangier disease. In: Scriver CR Beaudet AL Sly WS Childs B Kinzler KW Vogelstein B eds. The Metabolic and Molecular Basis of Inherited Disease. New York: McGraw-Hill; 2001: 2937–2980.

Cited by 153 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Very high HDL-C (high-density lipoprotein cholesterol) is associated with increased cardiovascular risk in patients with NSTEMI (non-ST-segment elevation myocardial infarction) undergoing PCI (percutaneous coronary intervention);BMC Cardiovascular Disorders;2023-07-17

2. Endothelial Function in Dyslipidemia: Roles of LDL-Cholesterol, HDL-Cholesterol and Triglycerides;Cells;2023-05-01

3. Apoproteins and Cell Surface Receptors Regulating Lipoprotein Metabolism in the Setting of Type 2 Diabetes;Contemporary Diabetes;2023

4. Acrolein, an environmental toxicant and its applications to in vivo and in vitro atherosclerosis models: An update;Environmental Toxicology and Pharmacology;2022-07

5. Rosmarinic Acid Exhibits a Lipid-Lowering Effect by Modulating the Expression of Reverse Cholesterol Transporters and Lipid Metabolism in High-Fat Diet-Fed Mice;Biomolecules;2021-10-06